Drug firm AstraZeneca Pharma India Ltd on Tuesday posted a net loss of Rs 18.57 crore for the fourth quarter ended March 31, 2013. The company had... ...http://www.moneycontrol.com/news/results/astrazeneca-q4-net-loss-at-rs-19-crore_877336.html
Forty eight private sector companies in India having a public shareholding of less than 25 per cent are expected to offload shares worth about $1.8... ...http://www.deccanherald.com/content/333828/pvt-firms-need-sell-shares.html
We recommend a sell in the stock of Aurobindo Pharma from a short-term perspective. It is seen from the charts of the stock that following a... ...http://www.thehindubusinessline.com/markets/todays-pick/aurobindo-pharma-rs-1808-sell/article4736629.ece
Pitches for more greenfield investments from abroad New Delhi, May 21: The Commerce Standing Committee of Parliament has expressed concern at the... ...http://www.thehindubusinessline.com/industry-and-economy/fdi-in-pharma-has-resulted-more-in-mergers-and-buys-says-panel/article4736431.ece
Coal India, BHEL, TCS, Infosys and Sun Pharma were the top five gainers, while NTPC, Tata Motors, Maruti, SBI and Tata Steel were the top five... ...http://news.in.msn.com/business/article.aspx?cp-documentid=253051882
RYAN PHARMA IS A FAST GROWING COMPANY
i want to do pharma business do you...
GMP Pharma Institute Private Limited...